Skip to content
Skip to main navigation
Skip to 1st column
Skip to 2nd column
You are here:
Home
MesotheliomaNews
2007
Search
mesothelioma
Home
Mesothelioma
Asbestos Cancer
Treatment
Asbestos Info
Glossary
News
Cancer Research
Sotries
Mesothelioma News 07
Title Filter
Display #
5
10
15
20
25
30
50
100
All
#
Article Title
Hits
1
FDA Designates Onconase (Ranpirnase) As Orphan Drug for Treatment of Malignant Mesothelioma
102
2
NYU Study Validates Use Of MESOMARK Test For Monitoring Mesothelioma
88
3
Hyperthermia Enhances Effectiveness of Onconase
87
4
Further EPA Testing at Alviso Superfund Site
109
5
Onconase (Ranpirnase) Could be Chemopreventive Agent in Mesothelioma
72
6
Pathway for Treatment of Malignant Pleural Mesothelioma
89
7
Data Affirm Benefit of Alimta (pemetrexed)
84
8
New diagnostic tool for mesothelioma to be developed
88
9
Alfacell Awkward Wait
83
10
Alfacell Updates Progress of Phase III Trial
90
«
Start
Prev
1
2
3
4
Next
End
»
Page 1 of 4
year list
08-09
2007
05-06
04-05
Mesothelioma
Mesothelioma Causes
Mesothelioma Symptoms
Mesothelioma Diagnosis
Types of Mesothelioma
Pleural Mesothelioma
Peritoneal Mesothelioma
Pericardial Mesothelioma
Treatment Options
Clinical Trials
Treatment Options
Surgery
Chemotherapy
Other Options
Asbestos
Overview
Asbestos Exposure
Types of Asbestos
Asbestosis
Asbestos Abatement
Other Related Diseases
Asbestosis
Lung Cancer
Small Cell
Non-Small Cell
MesotheliomaNews 2007
MesotheliomaNews 2007
MesotheliomaNews 2007
